Hepatitis B experts from around the world met at the 65th annual American Association for the Study of Liver Diseases (AASLD) conference in Washington D.C. this week to share the latest in hepatitis B treatment and research. Here are some of the highlights.
1. Which combination of antivirals and interferon works best against hepatitis B
A combination of antivirals and interferon led to a cure for hepatitis C, and researchers are trying similar combinations to find a cure for hepatitis B.
A large study involving 740 patients finds simultaneous tenofovir (Viread) and pegylated interferon (Pegasys) treatment works best. They found that 48 weeks of the paired tenofovir and interferon treatment was more effective than sequential antiviral-interferon treatment or using tenofovir or interferon alone.
Labels: AASLD 2014